sales and marketing rights for Elevess to San Diego-based Artes Medical Inc

AVI BioPharma Inc., of Corvallis, Ore., said partner Global Therapeutics, a unit of Bloomington, Ind.-based medical device firm Cook Medical Inc., received CE Mark approval for its GTX coronary stent

Company Product Marketer (at time of approval) Indication (U.S. Approval Date, Month/Year) 1982 Genentech Inc. Humulin Eli Lilly and Co. Diabetes (10/82) 1985 Genentech Inc. Protropin Genentech Inc. Growth hormone inadequacy; growth failure associated with chronic renal insufficiency in children (10/85) 1986 Biogen Inc.* Intron-A Schering-Plough Corp. Hairy cell leukemia (6/86); genital warts (6/88); AIDS-related Kaposi’s sarcoma (11/88); hepatitis C (2/91); hepatitis B (7/92

Artes Medical Inc., of San Diego, is funding a study to be led by Mary Olszewski, a Chicago-based podiatrist, to evaluate ArteFill for the treatment of foot pain in the plantar metatarsal area, or the ball of the foot

The company, however, intends to move forward with development of AVI-5126 in cardiovascular restenosis, for which it is partnered with Bloomington, Ind.-based medical device firm Cook Medical Inc

the round was completed by private and corporate investors, including Secure Medical Inc., CellCeuticals Skin Care Inc

The round was completed by private and corporate investors, including Secure Medical Inc., CellCeuticals Skin Care Inc., and Leonard H. Lavin, founder and chairman emeritus of the Alberto-Culver Co

Medical Inc.*Exclusive licensing agreement to employ one of Angiotech's PEG-based biomaterials as part of a prophylactic therapy to mitigate the onset of post-operative atrial fibrillation for patients under-going coronary artery bypass grafting and cardiac valve surgeries Angiotech receives an equity position in Symphony Medical in exchange for the exclusive license in the field of POAF (1/18) Anthera Pharmaceuticals Inc.*Amgen Inc. (AMGN) Licensing agreement for exclusive worldwide rights

Angiotech Pharmaceuticals Inc., of Vancouver, British Columbia, and Symphony Medical Inc., of Laguna Hills, Calif., have entered into an exclusive licensing agreement to employ one of Angiotech's PEG-based biomaterials as part of a prophylactic therapy to mitigate the onset of post-operative atrial fibrillation for patients undergoing coronary artery bypass grafting and cardiac valve surgeries

Gained through the April 2005 buyout of Orphan Medical Inc., Xyrem - called JZP-6 for FMS - is undergoing two pivotal Phase III trials, with data expected around the time when more milnacipran data pops, during the second half of this year

January | February | March | April | May | June | July | August | September | October | November | December | December - 2008 Company Company Type/Product Area Terms/Details AAIPharma Inc. (PK:AAIIQ) Cortria Corp. Agreement granting Cortria the right to use AAIPharma's controlled-release drug delivery technology, ProCR, in conjunction with its TRIA-662 TRIA-662 is Cortria's lead candidate in Phase II development for dyslipidemia Advanced Cell Technology Inc. (PK:ACTC) CHA

Medical Inc. (ARTE) Private placement of common stock and warrants 2.7S and W for 1.3S $2.4 Bioniche Life Sciences Inc. (Canada; TSX:BNC) Conversion of a revolving facility into equity 4.6S $1.85 Cell Therapeutics Inc. (CTIC) Private placement of convertible senior notes N/A $23.2 ChemGenex Pharmaceuticals Ltd. (Australia; CXSP) Private placement of common stock N/A A$12.9 ($10.1) Clinical Data Inc. (CLDA) Private placement of common stock and warrants 1.5S

Emmaus Medical Inc., of Torrance, Calif., has entered into an exclusive sublicense agreement with Cato BioVentures, of Research Triangle Park, N.C., for the NutreStore brand L-Glutamine

Company Product Marketer (at time of approval) Indication (U.S. Approval Date, Month/Year) 1982 Genentech Inc. Humulin Eli Lilly and Co. Diabetes (10/82) 1985 Genentech Inc. Protropin Genentech Inc. Growth hormone inadequacy; growth failure associated with chronic renal insufficiency in children (10/85) 1986 Biogen Inc.* Intron-A Schering-Plough Corp. Hairy cell leukemia (6/86); genital warts (6/88); AIDS-related Kaposi's sarcoma (11/88); hepatitis C (2/91); hepatitis B (7/92

VisEn Medical Inc., of Woburn, Mass., appointed Tarif Awad director of external scientific collaborations

Aethlon Medical Inc., of San Diego, said it will initiate research studies to test the in vitro effectiveness of its Hemopurifier medical device to capture H5N1 avian influenza, through collaborations with Commonwealth Biotechnologies Inc., of Richmond, Va., and Battelle Biomedical Research Center

Last year, Integra bought an orthopedic implant and surgical device business from Kinetikos Medical Inc., surgical and dental hand instruments from Miltex Inc

Sirtex Medical Inc., of Wilmington, Mass., named Samuel G. Putnam medical director for its U.S

Aethlon Medical Inc., of San Diego, said researchers have discovered the Aethlon Hemopurifier is effective in capturing particles that suppress the immune response in cancer patients